iBio, Inc.
IBIO
$0.85
$0.000.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.52M | -16.13M | -19.30M | -23.15M | -24.91M |
| Total Depreciation and Amortization | 852.00K | 840.00K | 1.18M | 1.21M | 1.25M |
| Total Amortization of Deferred Charges | -- | 0.00 | 0.00 | 30.00K | 120.00K |
| Total Other Non-Cash Items | 1.10M | 5.75M | 5.03M | 7.85M | 8.15M |
| Change in Net Operating Assets | -639.00K | -2.90M | -3.00M | -2.87M | -3.17M |
| Cash from Operations | -12.20M | -12.44M | -16.09M | -16.93M | -18.55M |
| Capital Expenditure | -2.00K | -211.00K | -211.00K | -210.00K | -210.00K |
| Sale of Property, Plant, and Equipment | -- | 66.00K | 66.00K | 66.00K | 116.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 758.00K | 712.00K | 1.71M | 1.71M | 1.00M |
| Cash from Investing | 756.00K | 567.00K | 1.57M | 1.57M | 906.00K |
| Total Debt Issued | -- | 0.00 | 895.00K | 895.00K | 895.00K |
| Total Debt Repaid | -519.00K | -1.58M | -1.72M | -1.66M | -2.03M |
| Issuance of Common Stock | 2.43M | 14.34M | 18.62M | 22.72M | 25.73M |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | -7.00K | -7.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5.95M | -88.00K | -88.00K | -88.00K | -88.00K |
| Cash from Financing | 7.87M | 12.68M | 17.70M | 21.86M | 24.49M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.58M | 807.00K | 3.18M | 6.50M | 6.85M |